The peptidomimetic, 1-adamantyl-substituted, and flex-het classes of retinoid-derived molecules: structure-activity relationships and retinoid receptor-independent anticancer activities.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2010-05-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138955710791384045PMID 20370709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

  2009cited by this paper
• SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule–mediated nuclear factor-κB activation, c-Fos/c-Jun expression, and cellular apoptosis

  2009cited by this paper
• Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: enhanced DNA damage response

  2009cited by this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study.

  2009cited by this paper
• PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation.

  2009cited by this paper
• The role of CYP26 enzymes in retinoic acid clearance

  2009cited by this paper
• Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo

  2008cited by this paper
• Inhibition of IkappaB kinase-beta and anticancer activities of novel chalcone adamantyl arotinoids.

  2008cited by this paper
• Design and synthesis of 4-HPR derivatives for rhabdoid tumors.

  2008cited by this paper
• Endoplasmic reticulum stress responses

  2008cited by this paper
• CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.

  2008cited by this paper
• Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containin

  2008cited by this paper
• Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity

  2008cited by this paper
• Synthetic retinoid CD437 induces mitochondria-mediated apoptosis in hepatocellular carcinoma cells.

  2008cited by this paper
• 4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cells.

  2008cited by this paper
• Synthetic retinoid fenretinide in breast cancer chemoprevention

  2007cited by this paper
• Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-Hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells

  2007cited by this paper
• An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: effects of modifying its carboxylate group on apoptosis, proliferation, and protein-tyrosine phosphatase activity.

  2007cited by this paper
• Novel cell death pathways induced by N-(4-hydroxyphenyl)retinamide: therapeutic implications

  2007cited by this paper
• Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria

  2007cited by this paper
• Involvement of TR3/Nur77 translocation to the endoplasmic reticulum in ER stress-induced apoptosis.

  2007cited by this paper
• Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.

  2007cited by this paper
• Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.

  2007cited by this paper
• Fenretinide up-regulates DR5/TRAIL-R2 expression via the induction of the transcription factor CHOP and combined treatment with fenretinide and TRAIL induces synergistic apoptosis in colon cancer cell lines.

  2007cited by this paper
• The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.

  2007cited by this paper
• The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.

  2007cited by this paper
• Synthesis and structure-activity relationships of new antiproliferative and proapoptotic retinoid-related biphenyl-4-yl-acrylic acids.

  2007cited by this paper
• Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models.

  2007cited by this paper
• Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP).

  2006cited by this paper
• N-(4-Hydroxyphenyl)retinamide-induced apoptosis triggered by reactive oxygen species is mediated by activation of MAPKs in head and neck squamous carcinoma cells

  2006cited by this paper
• Synthesis and preliminary chemotherapeutic evaluation of the fully C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.

  2006cited by this paper
• Antitumor Activity of the Retinoid-Related Molecules (E)-3-(4′-Hydroxy-3′-adamantylbiphenyl-4-yl)acrylic Acid (ST1926) and 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) in F9 Teratocarcinoma: Role of Retinoic Acid Receptor γ and Retinoid-Independent Pathways

  2006cited by this paper
• High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2

  2006cited by this paper
• Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-kappaB activation.

  2005cited by this paper
• Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists

  2005cited by this paper
• ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene.

  2005cited by this paper
• Inhibition of mammary tumor growth by a novel nontoxic retinoid: chemotherapeutic evaluation of a C-linked analog of 4-HPR-glucuronide.

  2005cited by this paper
• CD437, a synthetic retinoid, induces apoptosis in human respiratory epithelial cells via caspase-independent mitochondrial and caspase-8-dependent pathways both up-regulated by JNK signaling pathway.

  2005cited by this paper
• The Transforming Growth Factor-β Family Members Bone Morphogenetic Protein-2 and Macrophage Inhibitory Cytokine-1 as Mediators of the Antiangiogenic Activity of N-(4-Hydroxyphenyl)Retinamide

  2005cited by this paper
• Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response.

  2005cited by this paper
• Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.

  2005cited by this paper
• Randomized trial of fenretinide (4‐HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long‐term results

  2005cited by this paper
• Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.

  2004cited by this paper
• NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.

  2004cited by this paper
• Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.

  2004cited by this paper
• ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.

  2004cited by this paper
• Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities

  2004cited by this paper
• Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest.

  2004cited by this paper
• Retinoid related molecules an emerging class of apoptotic agents with promising therapeutic potential in oncology: pharmacological activity and mechanisms of action.

  2004cited by this paper
• Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells.

  2004cited by this paper
• Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity

  2004cited by this paper
• Retinoid targets for apoptosis induction

  2003cited by this paper
• Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway.

  2003cited by this paper
• A novel atypical retinoid endowed with proapoptotic and antitumor activity.

  2003cited by this paper
• Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway

  2003cited by this paper
• Identification and Characterization of a Cell Cycle and Apoptosis Regulatory Protein-1 as a Novel Mediator of Apoptosis Signaling by Retinoid CD437*

  2003cited by this paper
• Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.

  2003cited by this paper
• Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis.

  2003cited by this paper
• The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway.

  2003cited by this paper
• Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog.

  2002cited by this paper
• Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway.

  2002cited by this paper
• The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.

  2002cited by this paper
• Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis

  2002cited by this paper
• Upregulation of GADD153 expression in the apoptotic signaling of N‐(4‐hydroxyphenyl)retinamide (4HPR)

  2002cited by this paper
• An improved synthesis of the C-linked glucuronide of N-(4-hydroxyphenyl)retinamide.

  2002cited by this paper
• Retinoid-related molecules induce cytochrome c release and apoptosis through activation of c-Jun NH(2)-terminal kinase/p38 mitogen-activated protein kinases.

  2001cited by this paper
• Linear competitive inhibition of human tissue kallikrein by 4-aminobenzamidine and benzamidine and linear mixed inhibition by 4-nitroaniline and aniline.

  2001cited by this paper
• Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.

  2001cited by this paper
• Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis.

  2001cited by this paper
• Mitochondrial Respiration Is Uniquely Associated with the Prooxidant and Apoptotic Effects ofN-(4-Hydroxyphenyl)retinamide*

  2001cited by this paper
• Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2

  2001cited by this paper
• Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells

  2001cited by this paper
• Synthesis and biological activity of glycosyl conjugates of N-(4-hydroxyphenyl)retinamide.

  2001cited by this paper
• Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN)

  2001cited by this paper
• Effects of a novel synthetic retinoid on malignant glioma in vitro: inhibition of cell proliferation, induction of apoptosis and differentiation.

  2001cited by this paper
• An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies.

  2001cited by this paper
• Activation of nuclear transcription factor kappa B (NF‐κB) is essential for dopamine‐induced apoptosis in PC12 cells

  2001cited by this paper
• Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.

  2000cited by this paper
• Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors

  2000cited by this paper
• S-phase arrest and apoptosis induced in normal mammary epithelial cells by a novel retinoid.

  2000cited by this paper
• Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells.

  2000cited by this paper
• Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents.

  2000cited by this paper
• Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.

  2000cited by this paper
• Identification of a unique binding protein specific for a novel retinoid inducing cellular apoptosis

  2000cited by this paper
• Synthetic retinoid CD437 induces S‐phase arrest and apoptosis in human prostate cancer cells LNCaP and PC‐3

  1999cited by this paper
• Chemopreventive activity of a C-glucuronide analog of N-(4-hydroxyphenyl) retinamide-O-glucuronide against mammary tumor development and growth.

  1999cited by this paper
• In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARα protein and the PML retargeting on PML-nuclear bodies

  1999cited by this paper
• Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.

  1999cited by this paper
• Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid.

  1999cited by this paper
• Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437.

  1999cited by this paper
• A selective retinoid with high activity against an androgen‐resistant prostate cancer cell type

  1999cited by this paper
• Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.

  1999cited by this paper
• Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.

  1999cited by this paper
• Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis.

  1999cited by this paper
• Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.

  1999cited by this paper
• Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.

  1998cited by this paper
• Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways

  1998cited by this paper
• Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo

  1998cited by this paper
• Selective Activation of an Apoptotic Retinoid Precursor in Macrophage Cell Lines*

  1998cited by this paper
• Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

  1998cited by this paper

• Synthesis and Crystal Structure of Adamantylated 4,5,6,7-Tetrahalogeno-1H-benzimidazoles Novel Multi-Target Ligands (Potential CK2, M2 and SARS-CoV-2 Inhibitors); X-ray/DFT/QTAIM/Hirshfeld Surfaces/Molecular Docking Study

  2022cites this paper
• Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases.

  2019cites this paper
• 3‐Cl‐AHPC inhibits pro‐HGF maturation by inducing matriptase/HAI‐1 complex formation

  2018cites this paper
• Natural and Structure-based RXR Ligand Scaffolds and Their Functions.

  2017cites this paper
• SHetA2, a New Cancer-Preventive Drug Candidate

  2016cites this paper
• Targeting Estrogen Receptor Negative Breast Cancer Cells Using Diarylthiourea Analogs of SHetA2

  2016cites this paper
• Use of Retinoid Receptor Ligands to Identify Other Nuclear Receptor Ligands

  2015cites this paper
• Cytotoxic activity of some novel sulfonamide derivatives.

  2015cites this paper
• Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents.

  2015cites this paper
• Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells

  2015cites this paper
• Functions, therapeutic applications, and synthesis of retinoids and carotenoids.

  2014cites this paper
• Inhibition of IκB kinase-β and IκB kinase-α by heterocyclic adamantyl arotinoids.

  2014cites this paper
• The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

  2013cites this paper
• Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R

  2013cites this paper
• Adamantyl Arotinoids That Inhibit IκB Kinase α and IκB Kinase β

  2013cites this paper
• Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs

  2013cites this paper
• Retinoid chemistry: synthesis and application for metabolic disease.

  2012cites this paper
• Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomas.

  2011cites this paper